Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlo Vitagliano
Observed names:
C. Vitagliano,
Vitagliano, Carlo,
carlo vitagliano
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0000-0003-0352-7580
Observed ORCID:
0000-0003-0352-7580
OpenAlex ID:
A5067911315
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
2019
·
Chiara Ciardiello
, Alessandra Leone
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
132
PDF
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
2015
·
Francesca Collina
, Maurizio Di Bonito
, et al.
·
BioMed Research International
·
113
PDF
Golgi maturation‐dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3
2021
·
Riccardo Rizzo
, Domenico Russo
, et al.
·
The EMBO Journal
·
106
PDF
Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression
2015
·
Manuela Terranova-Barberio
, Maria Serena Roca
, et al.
·
Oncotarget
·
88
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway
2015
·
Alessandra Leone
, Maria Serena Roca
, et al.
·
Free Radical Biology and Medicine
·
87
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
2020
·
Federica Iannelli
, Maria Serena Roca
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
66
PDF
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges
2018
·
Paola Lanuti
, Pasquale Simeone
, et al.
·
Scientific Reports
·
60
PDF
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
2022
·
Maria Serena Roca
, Tania Moccia
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
49
PDF
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
2020
·
Federica Iannelli
, Andrea Ilaria Zotti
, et al.
·
Frontiers in Cell and Developmental Biology
·
36
491P Neoadjuvant nivolumab in early stage colorectal cancer
2020
·
A. Avallone
, A. De Stefano
, et al.
·
Annals of Oncology
·
34
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression
2016
·
Chiara Ciardiello
, Maria Serena Roca
, et al.
·
Oncotarget
·
27
PDF
Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection
2023
·
Susan Costantini
, Elena Di Gennaro
, et al.
·
Frontiers in Oncology
·
22
PDF
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy
2025
·
Susan Costantini
, Gabriele Madonna
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
20
PDF
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS -mutated metastatic colorectal cancer: the REVOLUTION study protocol
2020
·
Antonio Avallone
, Maria Carmela Piccirillo
, et al.
·
Therapeutic Advances in Medical Oncology
·
19
Synthesis and Evaluation of the Antitumor Properties of a Small Collection of PtII Complexes with 7‐Deazaadenosine as Scaffold
2017
·
Stefano D'Errico
, Nicola Borbone
, et al.
·
European Journal of Organic Chemistry
·
10
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
2023
·
C. Cardone
, A. De Stefano
, et al.
·
ESMO Open
·
8
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
2022
·
Maria Serena Roca
, Tania Moccia
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
4
PDF
Intermittent or continuous panitumumab plus FOLFIRI (FOLFIRI/PANI) for first-line treatment of patients (pts) with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): An update of survival/toxicity and preliminary results of genomic alterations from IMPROVE study.
2023
·
Antonio Avallone
, Francesco Giuliani
, et al.
·
Journal of Clinical Oncology
·
3
PDF
Abstract 1840: Repurposing of valproic acid and simvastatin in pancreatic cancer: in vitro and in vivo synergistic antitumor interaction and sensitization to gemcitabine/nab-paclitaxel via inhibition of TGFβ-EMT signaling pathway
2022
·
Maria Serena Roca
, federica iannelli
, et al.
·
Cancer Research
·
3
Assessing Urinary Para-Hydroxyphenylacetic Acid as a Biomarker Candidate in Neuroendocrine Neoplasms
2024
·
Renato de Falco
, Susan Costantini
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
SO-26 Intermittent or continuous panitumumab plus FOLFIRI for first-line treatment of patients with RAS/BRAF wild-type metastatic colorectal cancer: An update of survival/toxicity and preliminary results of genomic alterations from IMPROVE study
2023
·
A. De Stefano
, F. Giuliani
, et al.
·
Annals of Oncology
·
2
PDF
Abstract 3700: Genomic alterations on first-line panitumumab plus FOLFIRI in metastatic colorectal cancer
2024
·
Antonio Avallone
, Francesco Giuliani
, et al.
·
Cancer Research
·
1
Abstract 4058: Preclinical and phase-2 clinical study of valproic acid administered in combination with cisplatin and cetuximab in recurrent/metastatic head and neck cancer
2017
·
Alfredo Budillon
, Andrea I. Zotti
, et al.
·
Cancer Research
·
1
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase 2 study
2022
·
Cardone, Claudia
, De Stefano, Alfonso
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Abstract 1353: Immunomodulatory effects of valproic acid in combination with cisplatin and cetuximab in head and neck squamous cell carcinoma
2022
·
Federica Iannelli
, Andrea Ilaria Zotti
, et al.
·
Cancer Research
Show more works
View as search
Works count:
47
Citation count:
893
H-index:
14
I10-index:
15
Year
Topic
Type